Clinical trial
Effect of Brivaracetam in Photosensitive Epileptic Subjects
NCT00401648 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00401648 |
|---|---|
| Title | Effect of Brivaracetam in Photosensitive Epileptic Subjects |
| Official title | A Placebo-controlled, Single-blind, Multi-center Study to Explore the Photoparoxysmal Response in Photosensitive Epileptic Subjects After One Single Oral Dose of Brivaracetam in Capsules. |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Brivaracetam |
| Enrollment | 20 |
| Start date | Sep 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Nov 20, 2006 |
| Last update posted | Dec 1, 2009 |
| Countries | France, Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: